1448P IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI localized cancers: Results of the digestive non-colorectal cancer cohorts
Christelle de la Fouchardière, A. Zaanan, Robert Cohen, S.M. Le Sourd, D. Tougeron, E. Soularue, Olivier Dubreuil, N. Williet, E. Samalin-Scalzi, Guillaume Piessen, V. Hautefeuille, M. Jary, Méher Ben Abdelghani, L. Evesque, Philippe Rochigneux, Ellen Blanc, F. Bibeau, A. DeMontfort, Clélia Coutzac
Topics & Concepts
MedicinePembrolizumabColorectal cancerOncologyInternal medicineCancerImmunotherapyCancer Immunotherapy and BiomarkersGastric Cancer Management and OutcomesColorectal Cancer Treatments and Studies